Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Abbv crawled time : 15:30 save search
Hernia Repair Market Worth $5.1 Billion | MarketsandMarkets™
Published: 2024-02-15 (Crawled : 15:30) - prnewswire.com
MDT | $81.29 0.89% -0.11% 4.1M
|
Health Technology
|
| O: 0.18%
H: 1.41%
C: 1.06%
BAX | $41.02 1.54% 0.8% 2.6M
|
Health Technology
|
| O: 0.28%
H: 3.8%
C: 2.99%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: 0.48%
H: 1.56%
C: 1.48%
IART | $29.38 1.38% 1.36% 1M
|
Health Technology
|
| O: 1.03%
H: 1.63%
C: 1.47%
market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published: 2024-02-12 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: -0.57%
H: 0.04%
C: -1.74%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -1.46%
H: 1.04%
C: 0.97%
LLY | News | $745.69 1.96% 0.04% 1.4M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: -0.48%
BMY | $48.99 -0.31% 0.84% 7.1M
|
Health Technology
|
| O: 0.02%
H: 0.46%
C: -0.14%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.83%
H: 0.7%
C: -0.27%
ABT | News | $107.59 0.49% 0.4% 3.1M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: -1.77%
H: 0.46%
C: 0.41%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: -0.4%
H: 1.6%
C: 1.54%
report health treatment care global market
Wearable Injectors Market Worth $15.1 Billion | MarketsandMarkets™
Published: 2024-02-09 (Crawled : 15:30) - prnewswire.com
MDT | $81.29 0.89% -0.11% 4.1M
|
Health Technology
|
| O: -0.12%
H: 0.09%
C: -1.27%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
UTHR | $234.445 0.16% 0.16% 420K
|
Health Technology
|
| O: 0.18%
H: 0.11%
C: 0.1%
TNDM | $35.01 10.34% 9.37% 2.3M
|
Health Technology
|
| O: 0.22%
H: 1.06%
C: 0.34%
MNKD | $4.15 0.97% 0.96% 1M
|
Health Technology
|
| O: 1.46%
H: 0.86%
C: 0.86%
PODD | $167.18 1.68% 1.65% 550K
|
Health Technology
|
| O: 0.14%
H: 0.28%
C: -2.21%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: 0.0%
H: 0.05%
C: -1.27%
market
Tissue Engineering Market worth $8.9 billion - Exclusive Report by MarketsandMarkets™
Published: 2023-12-18 (Crawled : 15:30) - prnewswire.com
SNNUF | $12.08 -1.12% 2.5K
|
Health Technology
|
| O: 0.87%
H: 0.0%
C: -1.79%
TRUMF | $16.488 -17.59% 1.7K
|
Health Technology
|
| O: -3.31%
H: 3.79%
C: -0.1%
TRUMY | $16.94 0.79% 52K
|
Manufacturing
|
| O: 0.4%
H: 0.18%
C: 0.0%
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: -0.46%
H: 0.79%
C: 0.15%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.68%
H: 0.89%
C: 0.27%
VCEL | $46.38 2.2% 2.16% 360K
|
Health Technology
|
| O: -0.41%
H: 1.01%
C: -6.49%
MDXG | $6.505 2.28% 2.23% 750K
|
Health Technology
|
| O: 0.33%
H: 1.56%
C: -2.22%
CLGN | $5.4 2.66% 0.38% 13K
|
Health Technology
|
| O: -3.07%
H: 2.17%
C: 0.79%
report market
Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets
Published: 2023-12-07 (Crawled : 15:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.66%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.97%
H: 0.3%
C: -0.19%
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: 1.97%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: 0.51%
H: 1.22%
C: 1.09%
IMNM | $14.66 -4.06% -4.37% 810K
|
Health Technology
|
| O: -0.64%
H: 1.67%
C: -1.16%
BIIB | $193.18 -0.48% -0.48% 1.2M
|
Health Technology
|
| O: 1.67%
H: 0.91%
C: 0.57%
antibody therapeutics market
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -1.33%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
GSK | News | $41.24 1.6% -0.58% 2.1M
|
Health Technology
|
| O: -0.03%
H: 0.28%
C: -0.41%
LLY | News | $745.69 1.96% 0.04% 1.4M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 0.05%
H: 5.74%
C: 3.18%
BIIB | $193.18 -0.48% -0.48% 1.2M
|
Health Technology
|
| O: 0.42%
H: 2.37%
C: 1.45%
disease parkinson's revenue research therapeutics market
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
Published: 2023-12-05 (Crawled : 15:30) - biospace.com/
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: 0.51%
H: 0.68%
C: 0.32%
abbvie intelligence research collaboration
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: 0.28%
H: 0.9%
C: 0.72%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.35%
H: 3.4%
C: 3.17%
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: 81.82%
H: 0.0%
C: 0.0%
elahere abbvie cancer tumor acquire therapy
Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: -0.63%
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: 0.52%
H: 0.57%
C: -0.56%
GSK | News | $41.24 1.6% -0.58% 2.1M
|
Health Technology
|
| O: -0.5%
H: 0.26%
C: -0.69%
LLY | News | $745.69 1.96% 0.04% 1.4M
|
Health Technology
|
| O: -1.47%
H: 0.0%
C: 0.0%
BMY | $48.99 -0.31% 0.84% 7.1M
|
Health Technology
|
| O: -0.37%
H: 1.54%
C: 0.89%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.04%
H: 0.76%
C: -0.16%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: 0.19%
H: 0.03%
C: -1.57%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: 0.22%
H: 0.15%
C: -0.98%
disease tumor market
AbbVie Declares Quarterly Dividend
Published: 2023-09-08 (Crawled : 15:30) - prnewswire.com
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -0.1%
H: 0.0%
C: 0.0%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
abbvie
Settlement Opens Doors for Biosimilars of Abbvie's Most Profitable Drug
Published: 2022-03-09 (Crawled : 15:30) - biospace.com/
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
drug set biosimilar
China Oncology Drugs Market to Cross $35.2 Billion by 2027 - Insights Into the Leading Therapies, Indications, Drugs, and Companies
Published: 2022-02-18 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: -2.99%
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: -0.73%
H: 0.23%
C: -0.98%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.19%
H: 0.72%
C: -0.46%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: -1.02%
H: 0.43%
C: -0.84%
drug china therapy
Celltrion Healthcare announces Canadian approval of Yuflyma, a high-concentration, low-volume, citrate-free, and latex-free Humira (adalimumab) biosimilar
Published: 2022-01-31 (Crawled : 15:30) - biospace.com/
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
health thc approval cel humira biosimilar
AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call
Published: 2022-01-05 (Crawled : 15:30) - biospace.com/
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
conference
Upadacitinib (RINVOQ®) Achieved Primary and Key Secondary Endpoints in First Phase 3 Induction Study in Patients with Crohn's Disease
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: 0.0%
disease phase 3
Global Dermatology Drugs Market Report 2020: Market is Expected to Advance Rapidly to 2023 - Long-term Forecast to 2030
Published: 2021-03-18 (Crawled : 15:30) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.56%
H: 0.83%
C: 0.02%
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: -0.35%
H: 0.8%
C: 0.16%
GSK | News | $41.24 1.6% -0.58% 2.1M
|
Health Technology
|
| O: 0.17%
H: 0.91%
C: 0.19%
BHC | $8.53 0.95% 0.0% 4M
|
Health Technology
|
| O: 0.45%
H: 0.93%
C: -1.85%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.99%
H: 0.95%
C: -0.22%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.45%
H: 0.7%
C: 0.43%
AMGN | News | $273.54 0.6% 0.65% 1.9M
|
Health Technology
|
| O: -1.54%
H: 2.76%
C: 1.63%
drug
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.